Healthcare delay in breast cancer patients: a case study in a low-density population region from Mexico

Future Oncology
Jorge Aarón Rangel-MéndezRosa Esther Moo-Puc

Abstract

To describe delay intervals, their impact on clinical stage and initiation of first oncologic treatment, and evaluate associated factors in breast cancer patients in Yucatan, Mexico, a low-density population region. A retrospective analysis was done of 92 medical records, and bivariate and multivariate models applied to identify associations between healthcare delay and several factors. System delay accounted for most of the delay (median: 86 days; 61% of delay). Socioeconomic status and delivery to tertiary-care hospital predicted delay. Clinical stage determined initiation of first oncologic treatment. Delay in treatment was largely due to system delay. Only a few variables explained this delay. Clinical stage had the strongest effect on initiation of first oncologic treatment.

References

May 14, 1998·British Journal of Cancer·C C BurgessS B Love
Jan 29, 1999·Annals of Surgery·P I TartterJ L Bernstein
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Volker ArndtHermann Brenner
Jan 13, 2004·The British Journal of Surgery·M D BarberJ M Dixon
Dec 21, 2006·British Journal of Cancer·N Saint-JacquesD Rayson
Jan 9, 2010·Salud pública de México·Karla Unger-Saldaña, Claudia Infante-Castañeda
Mar 5, 2011·The Breast : Official Journal of the European Society of Mastology·Kristin BrightSilvia C Formenti
Apr 19, 2011·BMC Cancer·Bachok Norsa'adahBiswa M Biswal
Mar 12, 2013·The Breast : Official Journal of the European Society of Mastology·F MoliniéB Tretarre
Dec 18, 2013·Journal of Epidemiology·Amornsak PoumDonald Maxwell Parkin
Mar 27, 2015·Cancer·Karla Unger-SaldañaJesús Miguel Lázaro-León
Aug 25, 2016·Salud pública de México·Angélica Ángeles-LlerenasMauricio Hernández-Ávila

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

BIRADS
RTCLD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.